Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication

Australian and New Zealand Journal of Psychiatry

Volumn 44, Issue 5, 2010, Pages 482-487

  Lewis, Andrew J ^b   Galbally, Megan ^a   Opie, Gillian ^a   Buist, Anne ^c  

^a MERCY HOSPITAL FOR WOMEN   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antidepressants; Birth outcomes; Depression; Pregnancy

Indexed keywords

ANTIDEPRESSANT AGENT;

APGAR SCORE; ARTICLE; AUSTRALIA; BECK DEPRESSION INVENTORY; BODY HEIGHT; CASE CONTROL STUDY; CHILD GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; GESTATIONAL AGE; GROWTH RATE; HEAD CIRCUMFERENCE; HUMAN; LOW BIRTH WEIGHT; NEWBORN; PERINATAL DRUG EXPOSURE; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURITY; PROSPECTIVE STUDY; PUERPERIUM; QUESTIONNAIRE; RISK ASSESSMENT; THIRD TRIMESTER PREGNANCY; BIRTH WEIGHT; CEPHALOMETRY; CHILD DEVELOPMENT; DRUG EFFECTS; FETOMATERNAL TRANSFUSION; FOLLOW UP; GROWTH, DEVELOPMENT AND AGING; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; PRENATAL EXPOSURE; TIME;

ANTIDEPRESSIVE AGENTS; APGAR SCORE; AUSTRALIA; BIRTH WEIGHT; BODY HEIGHT; CASE-CONTROL STUDIES; CEPHALOMETRY; CHILD DEVELOPMENT; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MALE; MATERNAL-FETAL EXCHANGE; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; TIME FACTORS;

EID: 77951262571     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.3109/00048670903559593     Document Type: Article

References (26)

1. Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol 2004; 103:698-709. (Pubitemid 40459031)
2. Robertson E, Grace S, Wallington T, Stewart DE. Antenatal risk factors for postpartum depression: a synthesis of recent literature. Gen Hosp Psychiatry 2004; 26:289-295. (Pubitemid 38962393)
3. Halbreich U. The association between pregnancy processes, preterm delivery, low birth weight, and postpartum depressions: the need for interdisciplinary integration. Am J Obstet Gynecol 2005; 193:1312-1322. (Pubitemid 41395098)
4. Jablensky AV, Morgan V, Zubrick SR, Bower C, Yellachich LA. Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry 2005; 162:79-91. (Pubitemid 40095676)
5. Murray L, Cooper P. Effects of postnatal depression on infant development. Arch Dis Child 1997; 77:99-101. (Pubitemid 27398209)
6. O 'Connor TG, Ben-Shlomo Y, Heron J, Golding J, Adams D, Glover V. Prenatal anxiety predicts individual differences in cortisol in pre-adolescent children. Biol Psychiatry 2005; 58:211-217. (Pubitemid 41112269)
7. American Psychiatric Association. Practice guidelines for major depressive disorder in adults. Am J Psychiatry 1993; 150 (Suppl 4):1-26
8. Cohen LS, Altshuler LL, Harlow BL et al . Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 2006; 295:499-507. (Pubitemid 43200344)
9. Andrade SE, Raebel MA, Brown J et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008; 198:194e1-e5. (Pubitemid 351146600)
10. Thendrick V, Stowe ZN, Altshuler LL, Hwang S, Lee E, Haynes D. Placental passage of antidepressant medications. Am J Psychiatry 2003; 160:993-996. (Pubitemid 41079587)
11. Rampono J, Proud S, Hackett LP, Kristensen JH, Ilett KF. A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate. Int J Neuropsychopharmacol 2004; 7:329-334. (Pubitemid 39166467)
12. Chambers CD, Hernandez-Diaz S, van Marter LJ et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006; 354:579-587. (Pubitemid 43209105)
13. Zeskind PS, Stephens LE. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehaviour. Pediatrics 2004; 113:368-376.
14. Nordeng H, Lindemann R, Perminov KV, Reikvam A. Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors. Acta Paediatr 2001; 90:288-291. (Pubitemid 32299548)
15. Casper RC, Fleisher BE, Lee-Ancajas JC et al. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 2003; 142:402-408.
16. Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry 2006; 63:898-906. (Pubitemid 44188483)
17. Wen SW, Yang Q, Garner P et al . Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol 2006; 194:961-966.
18. Kallen B. Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med 2004; 158: 312-316. (Pubitemid 38451555)
19. Cohen LS, Heller VL, Bailey JW, Grush L, Ablon JS, Bouffard SM. Birth outcomes following prenatal exposure to fluoxetine. Biol Psychiatry 2000; 48:996-1000.
20. Kulin NA, Pastuszak A, Sage SR et al . Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA 1998; 279:609-610. (Pubitemid 28110208)
21. Thendrick V, Smith LM, Suri R, Hwang SM, Haynes D, Altshuler L. Birth outcomes after prenatal exposure to antidepressant medication. Am J Obstet Gynecol 2003; 188:812-815. (Pubitemid 36332456)
22. Ericson A, Kallen B, Wiholm B-E. Delivery outcome after the use of antidepressants in early pregnancy. Eur J Clin Pharmacol 1999; 55:503-508. (Pubitemid 29446550)
23. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-fi ve years of evaluation. Clin Psychol Rev 1988; 8:77-100. (Pubitemid 18045797)
24. Katz R, Katz J, Shaw BF. Beck Depression Inventory and Hopelessness Scale. The use of psychological testing for treatment planning and outcomes assessment. In: Maruish, Mark E. (Ed). The use of psychological testing for treatment planning and outcomes assessment (2nd ed.). Mahwah: Lawrence Erlbaum Associates Publishers; 1999: 921-933.
25. Galbally M, Lewis AJ, Lum J, Buist AE. Serotonin discontinuation syndrome following in utero exposure to anti-depressant medication: a prospective controlled study. Aust N Z J Psychiatry 2009; 43:846-854.
26. Cohen J. Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Erlbaum , 1998.